Bmc2 vascular presentation
1 / 20

BMC2 Vascular Presentation - PowerPoint PPT Presentation

  • Uploaded on

BMC2 Vascular Presentation. Health Care Facility. BMC2 VIC Registry. Collaborative effort to assess and improve the quality and care outcomes of patients with peripheral vascular disease who undergo percutaneous arterial intervention. Process. Patient is referred from PCP

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'BMC2 Vascular Presentation' - deron

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Bmc2 vascular presentation

BMC2 Vascular Presentation

Health Care Facility

Bmc2 vic registry
BMC2 VIC Registry

  • Collaborative effort to assess and improve the quality and care outcomes of patients with peripheral vascular disease who undergo percutaneous arterial intervention


  • Patient is referred from PCP

  • Baseline data collected

    • Peripheral Arterial Questionnaire (PAQ) is completed by patient

      • Pertains to lower extremity revascularization

      • Consists of detailed inquiries about patients quality of life related to the disease process

  • Patient has peripheral vascular intervention


  • Follow-up data collected

    • 30 days post-intervention

      • Medication compliance

      • Lifestyle improvements (diet, exercise and smoking cessation

      • Vital signs

      • NIT ( non-invasive testing) such as ABI

      • Any complications

    • 6 months post-intervention

      • Patient completes PAQ

  • Data entered into registry

Coordinating center role
Coordinating Center Role

  • During site visits:

    • Ensures all cases included in registry

    • Verifies data accuracy through chart reviews

  • Provides

    • Site visit reports

    • Quarterly and annual quality reports

    • Education for participating organizations

  • Organizes collaborative meetings

Site visit reports
Site Visit Reports

  • Components:

    • Completeness and timeliness of data

    • Accuracy of data

      • TIER 1 & 2 errors

    • Meeting participation

      • Clinician lead

      • Data coordinator

    • Quality indicators

  • The organization receives a score for each component

Audit criteria
Audit Criteria

  • TIER1

    • Significant data abstraction errors that affect quality improvement goals.

      • Example: Abstractor fails to take credit on the website for a vascular complication documented in the patient’s medical record.

  • TIER 2

    • Minor errors or discrepancies.

      • Example: Data abstractor fails to document total contrast dose and the information is found in the patient’s medical record.

Tier 1 2 scores
TIER 1 & 2 Scores

  • A score is generated for TIER 1 & 2

    • Total number of errors in each TIER is divided by the number of cases audited

  • TIER 1 findings can impact pay-for-performance

    • A score of 0.3 or less is required for maximum payment

  • TIER 2 findings do not affect pay for performance scores.

Audit score
Audit Score

TIER 1- September 2011

TIER 2- September 2011

TIER 1- June 2012

TIER 2- June 2012

Paq follow up percentages

Exceeds Expectation

Attendance compliance
Attendance Compliance

  • Annual Michigan ACC Conference

    • American College of Cardiology

      • Vascular Coordinator and Lead Clinician attended conference September 29th to meet attendance criteria for the year.

Bmc2 vic registry goals
BMC2 VIC Registry Goals

  • PVI Physician Advisory Committee established goals & numerical targets in 2009

  • 2012 Goals:

    • Vascular access complication <3%

    • Post PVI transfusion <7%

    • Contrast Induced Nephropathy <4%

    • Medical Therapy

      • ASA discharge: >90%

      • Statin discharge: >75%

Vascular access complications ytd q2
Vascular Access ComplicationsYTD Q2

Outside expectations, Needs improvement

Post pvi transfusions ytd q2
Post PVI Transfusions YTD Q2

Exceeds Expectation

Contrast induced nephropathy ytd q2
Contrast Induced NephropathyYTD Q2

Exceeds Expectation

Nephropathy requiring dialysis ytd q2
Nephropathy Requiring DialysisYTD Q2

Meets Expectation

Quality indicators discharged on asa
Quality Indicators: Discharged on ASA

Outside Expectation Needs Improvement

Quality indicators discharged on statins
Quality Indicators: Discharged on Statins

Below Expectation

Goal: >75.00%

Strategy for index improvement
Strategy for Index Improvement

  • Increased integration of patient management with PCP

  • Interventionalist or Surgeon to order lipid panel and LFT at initial consult.

  • Interventionalist or Surgeon will prescribe Statin unless contraindicated.